These results and the fact that AP-2 factors bind the endogenous ERBB2 gene promoter [13,16] strongly suggest that AP-2 factors do effectively contribute to ERBB2 overexpression in breast cancer cells. The gene discussed is TFAP2A; the disease is breast cancer.